CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:
We have completed our semi-annual rebalance of the Warren Buffet Intrinsic Value Portfolio (WBIV). The number of constituents has been reduced by 5 to 64. The rules-based portfolio is comprised of 47 companies that were already in the portfolio before the rebalance and 17 new companies; 22 companies were dropped from the portfolio. The most notable additions to the portfolio are: Netflix (NFLX), Gilead Sciences (GILD), and Synopsys (SNPS). The most notable deletions from the portfolio are: Eli Lilly and Company (LLY), Broadcom (AVGO), Abbvie (ABBV), Applied Materials (AMAT), and Bristol-Myers Squibb (BMY). The average market cap of the WBIV is $254 million and the dividend yield is 1.3%. The most notable increases in sector weightings (vs. the September 2023 rebalance) are Information Technology, up 3.5% to a 34.4% weight, and Communication Services, up 3.3% to 6.3%; the largest decreases in sector weightings are Health Care, down 3.9% to 9.4%, and Materials, down 1.4% to a 1.6% weight.